Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iradimed (IRMD) Gross Profit (2016 - 2025)

Historic Gross Profit for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $16.5 million.

  • Iradimed's Gross Profit rose 1622.5% to $16.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.1 million, marking a year-over-year increase of 1281.95%. This contributed to the annual value of $56.3 million for FY2024, which is 1234.42% up from last year.
  • Iradimed's Gross Profit amounted to $16.5 million in Q3 2025, which was up 1622.5% from $16.0 million recorded in Q2 2025.
  • In the past 5 years, Iradimed's Gross Profit registered a high of $16.5 million during Q3 2025, and its lowest value of $7.1 million during Q1 2021.
  • For the 5-year period, Iradimed's Gross Profit averaged around $12.0 million, with its median value being $12.2 million (2023).
  • Data for Iradimed's Gross Profit shows a peak YoY increase of 4872.5% (in 2021) and a maximum YoY decrease of 925.93% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Iradimed's Gross Profit stood at $9.2 million in 2021, then increased by 21.3% to $11.2 million in 2022, then increased by 19.54% to $13.4 million in 2023, then increased by 10.05% to $14.8 million in 2024, then grew by 11.74% to $16.5 million in 2025.
  • Its Gross Profit was $16.5 million in Q3 2025, compared to $16.0 million in Q2 2025 and $14.8 million in Q1 2025.